An Assessment of the Effectiveness (Efficacy) of Odeston (Odeston®) in Patients With Chronic Cholecystitis in Real Medical Practice

Exclusion Criteria

• •Presence of stones in the gall bladder and bile ducts;
• •The presence of jaundice, cholestatic liver diseases, liver cirrhosis with decompensation;
• •Increased ALT, AST above the 3 upper limits of normal;
• •Hypersensitivity to the components of the drug Odeston;
• •Pregnancy and lactation;
• •Prolonged fasting and total parenteral nutrition;
• •Patients with symptoms of acute abdomen at the time of inclusion in the study;
• •Patients with symptoms of acute neurological pathology at the time of inclusion in the study and/or аcute cerebrovascular accident, a history of convulsive syndrome;
• •Presence of cancer;
• •Acute infectious diseases at the time of inclusion in the study;
• •Fever of any origin (above 37.5 C);
• •Patients with symptoms of heart failure;
• •Patients with symptoms of pulmonary failure;
• •Patients with symptoms of acute or chronic renal failure;
• •A decompensated form of diabetes;
• •Patients with signs of psychiatric disorders.